BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33637086)

  • 1. Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy.
    Liu J; Liu Q; Zhang X; Cui M; Li T; Zhang Y; Liao Q
    Cancer Cell Int; 2021 Feb; 21(1):137. PubMed ID: 33637086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
    Peng M
    Front Immunol; 2022; 13():970885. PubMed ID: 36003383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
    Zhou Q; Yan X; Liu W; Yin W; Xu H; Cheng D; Jiang X; Ren C
    Front Oncol; 2020; 10():586019. PubMed ID: 33425739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of TGFβ signaling competency predicts immune poor cancer conversion to immune rich and response to checkpoint blockade.
    Moore J; Gkantalis J; Guix I; Chou W; Yuen K; Lazar AA; Spitzer M; Combes AJ; Barcellos-Hoff MH
    bioRxiv; 2024 May; ():. PubMed ID: 38496519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of four immune subtypes in locally advanced rectal cancer treated with neoadjuvant chemotherapy for predicting the efficacy of subsequent immune checkpoint blockade.
    He L; Jin M; Jian D; Yang B; Dai N; Feng Y; Xiao H; Wang D
    Front Immunol; 2022; 13():955187. PubMed ID: 36238279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Crucial Gene Modules Related to the Efficiency of Anti-PD-1/PD-L1 Therapy and Comprehensive Analyses of a Novel Signature Based on These Modules.
    Wang W; Dong D; Chen L; Wang H; Bi B; Liu T
    Front Genet; 2022; 13():893380. PubMed ID: 35937997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data.
    Wang X; Jiang S; Zhou X; Wang X; Li L; Tang J
    Oncol Res; 2023; 31(5):697-714. PubMed ID: 37547756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.
    Hu R; Tao T; Yu L; Ding Q; Zhu G; Peng G; Zheng S; Yang L; Wu S
    Front Cell Dev Biol; 2021; 9():809588. PubMed ID: 35223867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade.
    Mei J; Cai Y; Xu R; Li Q; Chu J; Luo Z; Sun Y; Shi Y; Xu J; Li D; Liang S; Jiang Y; Liu J; Qian Z; Zhou J; Wan M; Yang Y; Zhu Y; Zhang Y; Yin Y
    Cancer Commun (Lond); 2024 May; 44(5):554-575. PubMed ID: 38507505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian pattern subtyping unveiling distinct immune landscapes in breast cancer patients for better immunotherapy.
    Xiong S; Zhu W; Wu L; Zhou T; Wang W; Zhang O; Xiong X; Liu Z; Luo D
    Cancer Immunol Immunother; 2023 Oct; 72(10):3293-3307. PubMed ID: 37462763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy
    Zhong W; Zhong H; Zhang F; Huang C; Lin Y; Huang J
    Front Mol Biosci; 2021; 8():684050. PubMed ID: 34250018
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
    Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
    Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy.
    Ghosh A; Ghosh A; Sinha A; Mathai S; Bhaumik J; Mukhopadhyay A; Maitra A; Biswas NK; Majumder PP; Sengupta S
    Tumour Biol; 2023; 45(1):55-69. PubMed ID: 37599552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
    Cao B; Wang Q; Zhang H; Zhu G; Lang J
    Oncoimmunology; 2018; 7(2):e1392427. PubMed ID: 29308323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic oncogene filaggrin (
    Chen L; Huang X; Xiong L; Chen W; An L; Wang H; Hong Y; Wang H
    Transl Androl Urol; 2022 Oct; 11(10):1419-1432. PubMed ID: 36386263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
    Wang Q; Li M; Yang M; Yang Y; Song F; Zhang W; Li X; Chen K
    Aging (Albany NY); 2020 Feb; 12(4):3312-3339. PubMed ID: 32091408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy.
    Sun S; Xu L; Zhang X; Pang L; Long Z; Deng C; Zhu J; Zhou S; Wan L; Pang B; Xiao Y
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
    Zhang E; He J; Zhang H; Shan L; Wu H; Zhang M; Song Y
    Front Genet; 2020; 11():595657. PubMed ID: 33281882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.